Strongyloides—An uncommon cause of eosinophilia whilst on durvalumab

BACKGROUND: In malignancy, eosinophils have been shown to play an important role in the tumour micro‐environment. Increasingly, development of eosinophilia with immune checkpoint inhibitor (ICI) use is thought to be predictive of prognosis and development of immune‐related adverse events. However, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Quah, Gaik Tin, Blanchard, Gillian, Miller, Neil, Wilson, Paul, Nordman, Ina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575490/
https://www.ncbi.nlm.nih.gov/pubmed/35852050
http://dx.doi.org/10.1002/cnr2.1682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575490/
https://www.ncbi.nlm.nih.gov/pubmed/35852050
http://dx.doi.org/10.1002/cnr2.1682

Ejemplares similares